Circle Cardiovascular Imaging (Circle CVI) has received clearance from the U.S. Food and Drug Administration (FDA) for cvi42 | Plaque, AI software for plaque analysis on coronary CT angiography (CCTA).
cvi42 | Plaque integrates into existing CT workflows and is compatible with all major vendor systems. Ultimately, the software provides clinicians with greater control over their data, improved study processing times, and enhanced workflow efficiency, the company said.
Medicare currently covers AI-enabled coronary plaque analysis from CCTA with Category III CPT code 0625T, but effective January 2026, AI-enabled coronary plaque analysis will be covered by permanent Category I CPT code 75XX6, Circle CVI noted.
